Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Catalin Adrian Buzea, Lorena Dima, Christoph U. Correll & Peter Manu. (2022) Drug–drug interactions involving antipsychotics and antihypertensives. Expert Opinion on Drug Metabolism & Toxicology 18:4, pages 285-298.
Read now
Read now
Christoffer Polcwiartek, Kristian Kragholm, Ole Schjerning, Claus Graff & Jimmi Nielsen. (2016) Cardiovascular safety of antipsychotics: a clinical overview. Expert Opinion on Drug Safety 15:5, pages 679-688.
Read now
Read now
Navin V Dargani & Anil K Malhotra. (2014) Safety profile of iloperidone in the treatment of schizophrenia. Expert Opinion on Drug Safety 13:2, pages 241-246.
Read now
Read now
William V Bobo. (2013) Asenapine, iloperidone and lurasidone: critical appraisal of the most recently approved pharmacotherapies for schizophrenia in adults. Expert Review of Clinical Pharmacology 6:1, pages 61-91.
Read now
Read now
Articles from other publishers (45)
Raele Donetha Robison, Mriganka Singh, Lan Jiang, Melissa Riester, Matthew Duprey, John E. McGeary, Parag Goyal, Wen-Chih Wu, Sebhat Erqou, Andrew Zullo, James L. Rudolph & Nicole Rogus-Pulia. (2023) Acute Antipsychotic Use and Presence of Dysphagia Among Older Veterans with Heart Failure. Journal of the American Medical Directors Association 24:9, pages 1303-1310.
Crossref
Crossref
Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, Mirko Manchia, Vincenzo De Luca, Felice Iasevoli & Christoph U. Correll. (2022) Clozapine’s multiple cellular mechanisms: What do we know after more than fifty years? A systematic review and critical assessment of translational mechanisms relevant for innovative strategies in treatment-resistant schizophrenia. Pharmacology & Therapeutics 236, pages 108236.
Crossref
Crossref
Prasad S. Nishtala & Te-yuan Chyou. (2022) An Updated Analysis of Psychotropic Medicine Utilisation in Older People in New Zealand from 2005 to 2019. Drugs & Aging 39:8, pages 657-669.
Crossref
Crossref
Marjaana Koponen, Blair Rajamaki, Piia Lavikainen, J. Simon Bell, Heidi Taipale, Antti Tanskanen, Sirpa Hartikainen & Anna-Maija Tolppanen. (2022) Antipsychotic Use and Risk of Stroke Among Community-Dwelling People With Alzheimer’s Disease. Journal of the American Medical Directors Association 23:6, pages 1059-1065.e4.
Crossref
Crossref
Teodora Andric, Karl Winckel, Timothy David Tanzer, Samantha Hollingworth, Lesley Smith, Katherine Isoardi, Olivier Tan & Dan Siskind. (2022) Estimation of cardiac QTc intervals in people prescribed antipsychotics: a comparison of correction factors. Therapeutic Advances in Psychopharmacology 12, pages 204512532211049.
Crossref
Crossref
Xiao-Qing Li, Xin-Ru Tang & Li-Liang Li. (2021) Antipsychotics cardiotoxicity: What's known and what's next. World Journal of Psychiatry 11:10, pages 736-753.
Crossref
Crossref
Teodora Andric, Karl Winckel, Timothy Tanzer, Samantha Hollingworth, Katherine Isoardi & Dan Siskind. (2021) Bazett's correction formula overestimates the corrected QT among patients with antipsychotic induced tachycardia. Schizophrenia Research 231, pages 22-23.
Crossref
Crossref
Arruje Hameed, Tahir Farooq & Sadia Shabbir. 2021. Endocrine Disrupting Chemicals-induced Metabolic Disorders and Treatment Strategies. Endocrine Disrupting Chemicals-induced Metabolic Disorders and Treatment Strategies
357
365
.
Amy Ronaldson, Lotte Elton, Simone Jayakumar, Anna Jieman, Kristoffer Halvorsrud & Kamaldeep Bhui. (2020) Severe mental illness and health service utilisation for nonpsychiatric medical disorders: A systematic review and meta-analysis. PLOS Medicine 17:9, pages e1003284.
Crossref
Crossref
João Pedro Aguiar, Filipa Alves da Costa, Toine Egberts, Hubert Leufkens & Patrick Souverein. (2020) The association between receptor binding affinity and metabolic side effect profile of antipsychotics and major cardio- and cerebrovascular events: A case/non-case study using VigiBase. European Neuropsychopharmacology 35, pages 30-38.
Crossref
Crossref
Mingjing Shao, Xiaodong Lin, Deguo Jiang, Hongjun Tian, Yong Xu, Lina Wang, Feng Ji, Chunhua Zhou, Xueqing Song & Chuanjun Zhuo. (2020) Depression and cardiovascular disease: Shared molecular mechanisms and clinical implications. Psychiatry Research 285, pages 112802.
Crossref
Crossref
Annamaria Mascolo, Cristina Scavone, Concetta Rafaniello & A. Capuano. 2020. Brain and Heart Dynamics. Brain and Heart Dynamics
721
729
.
Jingjing Zhu, Weihong Hou, Yong Xu, Feng Ji, Guowei Wang, Ce Chen, Chongguang Lin, Xiodong Lin, Jie Li, Chuanjun Zhuo & Mingjng Shao. (2019) Antipsychotic drugs and sudden cardiac death: A literature review of the challenges in the prediction, management, and future steps. Psychiatry Research 281, pages 112598.
Crossref
Crossref
Susana Alberich, Jessica Fernández-Sevillano, Itxaso González-Ortega, Judith Usall, Marga Sáenz, Eduardo González-Fraile & Ana González-Pinto. (2019) A systematic review of sex-based differences in effectiveness and adverse effects of clozapine. Psychiatry Research 280, pages 112506.
Crossref
Crossref
Chih‐Wan Huang, Yu‐Wen Chiu, Pei‐Jung Chen, Nan‐Wen Yu, Hui‐Ju Tsai & Chia‐Ming Chang. (2019) Trends and factors in antipsychotic use of outpatients with anxiety disorders in Taiwan, 2005–2013: A population‐based study. Psychiatry and Clinical Neurosciences 73:8, pages 501-507.
Crossref
Crossref
Vishal Bali, Pravin S. Kamble & Rajender R. Aparasu. (2015) Cardiovascular Safety of Concomitant Use of Atypical Antipsychotics and Long-Acting Stimulants in Children and Adolescents With ADHD. Journal of Attention Disorders 23:2, pages 163-172.
Crossref
Crossref
A. Mascolo, C. Scavone, C. Rafaniello & A. Capuano. 2019. Brain and Heart Dynamics. Brain and Heart Dynamics
1
10
.
Sayaka Nagasawa, Hisako Saitoh, Shiori Kasahara, Fumiko Chiba, Suguru Torimitsu, Hiroko Abe, Daisuke Yajima & Hirotaro Iwase. (2018) Relationship between KCNQ1 (LQT1) and KCNH2 (LQT2) gene mutations and sudden death during illegal drug use. Scientific Reports 8:1.
Crossref
Crossref
Brandi L. Bellissima, Malcolm D. Tingle, Aleksandar Cicović, Mohammed Alawami & Christopher Kenedi. (2018) A systematic review of clozapine-induced myocarditis. International Journal of Cardiology 259, pages 122-129.
Crossref
Crossref
Ruey-Hsing Chou, Li-Wei Lo, Ying-Jay Liou, Jiah-Hwang Shu, Hsiu-Chuan Hsu, Ying Liang, Chin-Chou Huang, Po-Hsun Huang, Shing-Jong Lin, Jaw-Wen Chen, Wan-Leong Chan & Hsin-Bang Leu. (2017) Antipsychotic treatment is associated with risk of atrial fibrillation: A nationwide nested case-control study. International Journal of Cardiology 227, pages 134-140.
Crossref
Crossref
James J. Gugger & Megan J. Ehret. 2016. Life-Threatening Effects of Antipsychotic Drugs. Life-Threatening Effects of Antipsychotic Drugs
81
101
.
Sayako Kamei, Noriko Sato, Yuta Harayama, Miyako Nunotani, Kanae Takatsu, Tetsuya Shiozaki, Tokutaro Hayashi & Hideki Asamura. (2013) Molecular analysis of potassium ion channel genes in sudden death cases among patients administered psychotropic drug therapy: are polymorphisms in LQT genes a potential risk factor?. Journal of Human Genetics 59:2, pages 95-99.
Crossref
Crossref
Jens-Uwe Peters. (2013) Polypharmacology – Foe or Friend?. Journal of Medicinal Chemistry 56:22, pages 8955-8971.
Crossref
Crossref
Karen L. Teff, Michael R. Rickels, Joanna Grudziak, Carissa Fuller, Huong-Lan Nguyen & Karl Rickels. (2013) Antipsychotic-Induced Insulin Resistance and Postprandial Hormonal Dysregulation Independent of Weight Gain or Psychiatric Disease. Diabetes 62:9, pages 3232-3240.
Crossref
Crossref
Jimmi Nielsen, John M Kane & Christoph U Correll. (2012) Real‐world effectiveness of clozapine in patients with bipolar disorder: results from a 2‐year mirror‐image study. Bipolar Disorders 14:8, pages 863-869.
Crossref
Crossref
Jimmi Nielsen, Rene Ernst Nielsen & Christoph U. Correll. (2012) Predictors of Clozapine Response in Patients With Treatment-Refractory Schizophrenia. Journal of Clinical Psychopharmacology 32:5, pages 678-683.
Crossref
Crossref
Rasmus Røge, Bjarne K. Møller, Christian R. Andersen, Christoph U. Correll & Jimmi Nielsen. (2012) Immunomodulatory effects of clozapine and their clinical implications: What have we learned so far?. Schizophrenia Research 140:1-3, pages 204-213.
Crossref
Crossref
Jimmi Nielsen, Charlotte Emborg, Susanne Gydesen, Jesper Dybbro, Jørgen Aagaard, Karsten Haderup, Pia Glyngdal, Susanne Fabricius, Dorrit Thode,Henrik Lublin, Torben Andersen, Per Damkier & David Taylor. (2012) Augmenting Clozapine With Sertindole. Journal of Clinical Psychopharmacology 32:2, pages 173-178.
Crossref
Crossref
Jens‐Uwe Peters. 2012. Polypharmacology in Drug Discovery. Polypharmacology in Drug Discovery
47
62
.
James J. Gugger. (2011) Antipsychotic Pharmacotherapy and Orthostatic Hypotension. CNS Drugs 25:8, pages 659-671.
Crossref
Crossref
Adrian Newman-Tancredi & Mark S. Kleven. (2011) Comparative pharmacology of antipsychotics possessing combined dopamine D2 and serotonin 5-HT1A receptor properties. Psychopharmacology 216:4, pages 451-473.
Crossref
Crossref
Iria Grande, Alexandre Pons, Immaculada Baeza, Ángela Torras & Miguel Bernardo. (2011)
QTc
prolongation: is clozapine safe? Study of 82 cases before and after clozapine treatment
. Human Psychopharmacology: Clinical and Experimental 26:6, pages 397-403.
Crossref
Crossref
Jimmi Nielsen, Claus Graff, Jørgen K. Kanters, Egon Toft, David Taylor & Jonathan M. Meyer. (2011) Assessing QT Interval Prolongation and its Associated Risks with Antipsychotics. CNS Drugs 25:6, pages 473-490.
Crossref
Crossref
J. Nielsen, P. Damkier, H. Lublin & D. Taylor. (2011) Optimizing clozapine treatment. Acta Psychiatrica Scandinavica 123:6, pages 411-422.
Crossref
Crossref
Sandhya Mehta, Hua Chen, Michael Johnson & Rajender R. Aparasu. (2011) Risk of Serious Cardiac Events in Older Adults Using Antipsychotic Agents. The American Journal of Geriatric Pharmacotherapy 9:2, pages 120-132.
Crossref
Crossref
Claire Lathers, Paul Schraeder & Michael Bungo. 2010. Sudden Death in Epilepsy. Sudden Death in Epilepsy.
Thomas J Raedler. (2010) Cardiovascular aspects of antipsychotics. Current Opinion in Psychiatry 23:6, pages 574-581.
Crossref
Crossref
Hilario Blasco-Fontecilla, Enrique Baca-Garcia & Jose de Leon. (2010) Do atypical antipsychotic drugs reduce the risk of ischemic heart disease and mortality? Possible role of 5-HT2A receptor blockade. Schizophrenia Research 119:1-3, pages 160-163.
Crossref
Crossref
Ramón Ramos-Ríos, Manuel Arrojo-Romero, Eduardo Paz-Silva, Fernando Carballal-Calvo, José L. Bouzón-Barreiro, Jorge Seoane-Prado, Rosario Codesido-Barcala, Alicia Crespí-Armenteros, Ramón Fernández-Pérez, Javier D. López-Moríñigo, Ignacio Tortajada-Bonaselt, Francisco J. Diaz & Jose de Leon. (2010) QTc interval in a sample of long-term schizophrenia inpatients. Schizophrenia Research 116:1, pages 35-43.
Crossref
Crossref
Peter Buckley. (2009) Clinical News. Clinical Schizophrenia & Related Psychoses 3:1, pages 15-17.
Crossref
Crossref
René Ernst NielsenJimmi Nielsen. (2009) Antipsychotic Drug Treatment for Patients with Schizophrenia: Theoretical Background, Clinical Considerations and Patient Preferences. Clinical Medicine. Therapeutics 1, pages CMT.S2175.
Crossref
Crossref
Peter J. Weiden, Andrew J. Cutler, Mihael H. Polymeropoulos & Curt D. Wolfgang. (2008) Safety Profile of Iloperidone. Journal of Clinical Psychopharmacology 28:2, pages S12-S19.
Crossref
Crossref
Claire M. Lathers, Paul L. Schraeder & Michael W. Bungo. (2008) The mystery of sudden death: Mechanisms for risks. Epilepsy & Behavior 12:1, pages 3-24.
Crossref
Crossref
Christoph U. Correll. (2014) Acute and Long-Term Adverse Effects of Antipsychotics. CNS Spectrums 12:S21, pages 10-14.
Crossref
Crossref
Andrea de Bartolomeis, Licia Vellucci, Annarita Barone, Mirko Manchia, Vincenzo De Luca, Felice Iasevoli & Christoph Correll. (2022) Clozapine's Multiple Cellular Mechanisms: What Do We Know after More than Fifty Years? a Systematic Review and Critical Assessment of Translational Mechanisms Relevant for Innovative Strategies in Treatment-Resistant Schizophrenia. SSRN Electronic Journal.
Crossref
Crossref